Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alejandro Tormo Micó, Radiotherapy
Hospital La Fe
Principal Investigator - Alex Casalots, Pathologist
Complejo Sanitario de Parc Taulí
Principal Investigator - Ana Darnell, Radiologist
Complejo Sanitario Parc Taulí
Study Director - Ana Hernández Machancoses, Radiotherapy
Hospital General Universitario de Valencia
Principal Investigator - Andrés Monzón, Surgeon
Hospital Miguel Servet
Principal Investigator - Anna Caltrava, Pathologist
Instituto Valenciano de Oncología (IVO)
Study Director - Antonieta Salud, Oncologist
Hospital Arnau de Villanova (Lérida)
Principal Investigator - Antonio Lazy, Surgeon
Hospital Clinic of Barcelona
Principal Investigator - Carles Conill, Radiotherapy
Hospital Clinic of Barcelona
Principal Investigator - Carles Pericay, Oncologist
Complejo Sanitario Parc Taulí
Study Director - Carlos Fernández Martos, Oncologist
Instituto Valenciano de Oncología (IVO)
Study Chair - Carlos Hörndler, Pathologist
Hospital Miguel Servet
Principal Investigator - Damián García Olmo, Surgeon
Hospital La Paz
Principal Investigator - Eloy Tejero, Surgeon
Hospital Clínico Universitario Lozano Blesa
Principal Investigator - Encarna Martínez, Pathologist
Hospital General Universitario de Valencia
Principal Investigator - Enrique Sierra Grañón, Surgeon
Hospital Arnau de Vilanova (Lérida)
Principal Investigator - Fernando Arias de la Vega, Radiotherapy
Hospital de Navarra
Principal Investigator - Fernando Mas Estellés, Radiologist
Hospital La Fe
Principal Investigator - Jaime Feliú, Oncologist
Hospital La Paz
Principal Investigator - Javier Gallego, Oncologist
Hospital General Universitario de Elche
Principal Investigator - Javier Jiménez, Radiologist
Hospital de Navarra
Principal Investigator - Javier Ortego, Pathologist
Hospital Clinico Universitario Lozano Blesa
Principal Investigator - Javier Suárez Alecha, Surgeon
Hospital de Navarra
Principal Investigator - Javier Valencia, Radiotherapy
Hospital Clínico Universitario Lozano Blesa
Principal Investigator - Jesús Santos, Radiologist
Instituto valenciano de Oncología (IVO)
Principal Investigator - Joan Maurel, Oncologist
Hospital Clinic of Barcelona
Principal Investigator - Jorge Aparicio, Oncologist
Hospital La Fe
Principal Investigator - Jorge Campos, Surgeon
Instituto Valenciano de Oncología (IVO)
Principal Investigator - José Antonio Fernández Gómez, Radiologist
Hospital Clínico Universitario Lozano Blesa
Principal Investigator - José Vicente Roig, Surgeon
Hospital General Universitario de Valencia
Principal Investigator - Juan Ramón Ayuso, Radiologist
Hospital Clinic of Barcelona
Principal Investigator - Luís Sarriá, Radiologist
Hospital Miguel Servet
Principal Investigator - Manuel Gallén, Oncologist
Hospital del Mar
Principal Investigator - Marta Martín Richard, Oncologist
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Principal Investigator - Martín Tejedor Gutierrez, Radiotherapy
Hospital Miguel Servet
Principal Investigator - María Elena Sánchez Santos, Radiotherapy
Hospital La Paz
Principal Investigator - María José Artes, Pathologist
Hospital La Fe
Principal Investigator - María José Safont, Oncologist
Hospital General Universitario de Valencia
Principal Investigator - María Luisa Gómez Dorronsoro, Pathologist
Hospital de Navarra
Principal Investigator - Mengual, Radiotherapy
Instituto Valenciano de Oncología (IVO)
Principal Investigator - Moisés Miraflores, Radiotherapy
Hospital Arnau de Vilanova (Lérida)
Principal Investigator - Paula Alegría Hidalgo, Radiologist
Hospital La Paz
Principal Investigator - Pilar Escudero, Oncologist
Hospital Clínico Universitario Lozano Blesa
Principal Investigator - Rafael Estevan, Surgeon
Hospital La Fe
Study Director - Ruth Vera, Oncologist
Hospital de Navarra
Principal Investigator - Vicente Alonso, Oncologist
Hospital Miguel Servet
Principal Investigator - Vicente Martínez Sanjuán, Radiologist
Hospital General Universitario de Valencia
Principal Investigator - Xavier Matias-Guiu Guia, Pathologist
Hospital Arnau de Vilanova (Lérida)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital General Universitario de Elche
Elche, Alicante, Spain
- Hospital Clinic I Provincial de Barcelona
Barcelona, Barcelona, Spain
- Hospital de la Santa Creu I Sant Pau
Barcelona, Barcelona, Spain
- Hospital del Mar
Barcelona, Barcelona, Spain
- Complejo Sanitario Parc Taulí
Sabadell, Barcelona, Spain
- Hospital Arnau de Vilanova
Lleida, Lérida, Spain
- Hospital la Paz
Madrid, Madrid, Spain
- Hospital de Navarra
Pamplona, Pamplona, Spain
- Hospital General de Valencia
Valencia, Valencia, Spain
- Hospital la Fe
Valencia, Valencia, Spain
- Instituto Valenciano de Oncología (ivo)
Valencia, Valencia, Spain
- Hospital Miguel Servet
Zaragoza, Zaragoza, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2009
- Primary completion
- 31 Jan 2013
- Completion
- 30 Jun 2013
- Last update posted
- 11 Oct 2013
- Registered enrollment
- 46
- Registry id
- NCT00909987
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.